Foslevodopa/Foscarbidopa Overnight Administration Improves Nocturia in Patients with Parkinson's Disease: Evidence from a Real‐World Study

20260 citationsJournal Article

Authors

This study supports the utility of the overnight dopaminergic stimulation with LDp/CDp CSCI in controlling overactive bladder.

Published in: Movement Disorders Clinical Practice

Field-Weighted Citation Impact: 0.00